SCHEMBL8796587

SCHEMBL8796587

C/C(=C\C=C(\C(=O)O)c1cccc(Br)c1)c1ccc2c(c1)C(C)(C)CCC2(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARG P13631 15/20 0.50
RXRA P19793 14/20 0.50
RARA P10276 13/20 0.50
RARB P10826 13/20 0.50
CYP26A1 O43174 3/20 0.50
KDM4E B2RXH2 1/20 0.50
NPC1 O15118 1/20 0.50
GMNN O75496 1/20 0.50
USP2 O75604 1/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
POLB P06746 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
NFKB1 P19838 1/20 0.50
CYP2C19 P33261 1/20 0.50
THPO P40225 1/20 0.50
MTOR P42345 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8796848 0.81 RXRA (0.43) RARGRXRARARARARBCYP26A1
SCHEMBL8795964 0.81 PTGS2 (0.57) RARGRXRARARARARBCYP26A1
SCHEMBL8795957 0.81 PTGS2 (0.57) RARGRXRARARARARBCYP26A1
SCHEMBL8919753 0.76 RXRA (0.56) RARGRXRARARARARBCYP26A1
SCHEMBL8924453 0.76 RXRA (0.56) RARGRXRARARARARBCYP26A1
SCHEMBL8796074 0.76 PLA2G4A (0.56) RARGRXRARARARARBCYP26A1
SCHEMBL8796081 0.76 PLA2G4A (0.56) RARGRXRARARARARBCYP26A1
SCHEMBL8796232 0.75 RXRA (0.39) RARGRXRARARARARBCYP26A1
SCHEMBL9860692 0.75 RARG (0.61) RARGRXRARARARARBCYP26A1
SCHEMBL8776377 0.75 RARG (0.61) RARGRXRARARARARBCYP26A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0629604-B1 Alicyclic phospholipase A2 inhibitors BRISTOL MYERS SQUIBB CO (US) 1997-04-16 EP disclosed
US-5436369-A Alicyclic phospholipase A2 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1995-07-25 US disclosed
EP-0629604-A2 Alicyclic phospholipase A2 inhibitors Bristol-Myers Company (US) 1994-12-21 EP disclosed